New DNA Tech: Creating Unicorns and Curing Cancer for Real?
By David Ewing Duncan,
The Daily Beast
| 03. 30. 2015
Untitled Document
“We have within our grasp the technology to change evolution. This could change the course of biological life.”
— Paul Berg, Nobel Laureate and a pioneer of genetic engineering
In 2012, scientists in the U.S. and Sweden invented a technology as potentially life-altering as splitting the atom. One that you haven’t heard of—yet—called “CRISPR-Cas9”. This innovation with the cumbrous name allows biologists to edit DNA almost as easily as cutting and pasting words and letters on a laptop.
Scientists say that CRISPR-Cas9 may soon allow them to perform miraculous fixes to eliminate or alter mutations that cause everything from some cancers to Parkinson’s disease. More whimsically, the technology could be used to create, say, a unicorn, or a pig with wings; though it’s unlikely they could make swine fly. More nefariously, terrorists or the military might create pathogens that could harm far more people than splitting the atom has so far. Or, an accident could occur unintentionally.
The question is how to turn this seemingly earth-shattering technology from a yawn in the public perception into a topic that...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...